7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 5g

4'-Bromoacetanilide>98.0%(GC)500g

({[4-chloro-3-(trifluoromethyl)phenyl]sulfonyl}amino)acetic acid, 95.0%, 1g

2H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-amine dihydrochloride, 98%, 100mg

2-[(1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoic acid, 98%, 1g

2-Chloro-6-methyl-4-(trifluoromethyl)nicotinonitrile, 95.0%, 5g

D(-)-Fructose, min. 99.5%, for biochemistry, 2.5 kg, plastic packaging.

Ethyl 4-chlorobenzoylformate, 96.0%, 5g

N-Methyl(3-(pyridin-4-yl)phenyl)methanamine, 95.0%, 250mg

9,9-Bis(4-amino-3-chlorophenyl)fluorene>98.0%(HPLC)(T)5g

tert-Butyl (6-fluoropyridin-2-yl)carbamate, 98%, 500mg

Ethyl 2-(3-iodophenyl)acetate, 97%, 1g

3-ETHYL-3-HYDROXY-AZETIDINE HCL, 97.0%, 1g